RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...

Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

The U.S. Centers for Disease Control and Prevention is predicting that hospitalizations caused by the flu, COVID-19 and respiratory syncytial virus will be similar to or lower than last fall and ...

First discovered in chimpanzees in 1956 and in children the following year, respiratory syncytial virus (RSV) isn’t new. Neither is it uncommon among the youngest and oldest populations ...

Fall respiratory virus season is here. For the next few months, cases of COVID-19, flu and respiratory syncytial virus, or RSV, are expected to rise as people gather indoors for the holidays.

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV) receiving care through the emergency department. Respiratory ...

Oct 8 (Reuters) - GSK (GSK.L), opens new tab said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in its third season after patients ...

HOUSTON, Texas (KTRK) -- Respiratory syncytial virus, or RSV, is the leading cause of hospitalizations for infants. It's a major risk for older children, too, and can be dangerous, even life ...